Diagnostic Accuracy of Imaging Modalities for Age-Related Macular Degeneration
Researchers at the University of Turin, Italy, have investigated the diagnostic accuracy of six imaging modalities for detecting macular atrophy in patients with previously treated neovascular age-related macular degeneration (AMD). The study, published in the British Journal of Ophthalmology, found that structural optical coherence tomography (OCT) demonstrated the highest diagnostic accuracy, with 92.4% sensitivity and 96.7% specificity. The researchers suggest that while other modalities may be useful as supplements, color fundus photography alone is limited in its ability to detect macular atrophy.
Key Takeaways:
- The study evaluated the diagnostic accuracy of six imaging modalities: color fundus photography (CFP), multicolor imaging (MC), blue autofluorescence (BAF), green autofluorescence (GAF), near-infrared reflectance (NIR), and structural optical coherence tomography (OCT).
- The study included 113 eyes from patients treated with anti-vascular endothelial growth factor for at least 1 year.
- Structural OCT detected macular atrophy in 43.4% of cases, followed by GAF (36.3%), BAF, and NIR (35.4% each), MC (33.6%), and CFP (30.1%).
- Structural OCT demonstrated the highest diagnostic accuracy, with 92.4% sensitivity and 96.7% specificity.
- Other modalities showed moderate sensitivity (64.1-77.4%) and specificity (75.0-88.3%).
- Inter-reader agreement was moderate for BAF (k=0.46) and lower for the remaining modalities, lowest for CFP (k=0.18).
- The study concluded that structural OCT offers the highest accuracy and reliability for detecting macular atrophy in neovascular AMD.
Statistics:
- 113 eyes from patients treated with anti-vascular endothelial growth factor for at least 1 year were included in the study.
- Structural OCT detected macular atrophy in 43.4% of cases.
- The sensitivity of structural OCT was 92.4% and its specificity was 96.7%.
- The inter-reader agreement for BAF was k=0.46 and for CFP was k=0.18.
- The study found moderate sensitivity (64.1-77.4%) and specificity (75.0-88.3%) for other imaging modalities.
Sources:
- British Journal of Ophthalmology. (2025). Comparative diagnostic performance of six imaging modalities for detecting macular atrophy in neovascular age-related macular degeneration.
- NewsRx. (2025, October 24). Reports Outline Age-Related Macular Degeneration Findings from University of Turin (Comparative diagnostic performance of six imaging modalities for detecting macular atrophy in neovascular age-related macular degeneration). Health & Medicine Week.